Dystrophic Epidermolysis Bullosa
Also known as: Epidermolysis bullosa dystrophica / Dystrophic epidermolysis bullosa (disorder) / Epidermolysis bullosa, unspecified / Epidermolysis Bullosa / Epidermolysis bullosa (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB17831 | Beremagene geperpavec | Gene therapy used to treat wounds associated with dystrophic epidermolysis bullosa. |
| DB16536 | Birch bark extract | A herbal medicinal product used to treat partial thickness wounds. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB16536 | Birch bark extract | Cytochrome P450 2C8 | enzyme |
| DB16536 | Birch bark extract | Cytochrome P450 3A Subfamily | enzyme |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB11994 | Diacerein | 1 | Completed | 1 |
| DB17831 | Beremagene geperpavec | 1 / 2 | Completed | 1 |
| DB17867 | QR-313 | 1 / 2 | Not Yet Recruiting | 1 |
| DB00099 | Filgrastim | 2 | Completed | 1 |
| DB17831 | Beremagene geperpavec | 3 | Completed | 2 |